Australia - inglés - Department of Health (Therapeutic Goods Administration)

generic partners pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: magnesium stearate; purified talc; colloidal anhydrous silica; calcium hydrogen phosphate dihydrate; lactose monohydrate; ammonio methacrylate copolymer - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

generic partners pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; purified talc; magnesium stearate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

Bélgica - inglés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vemedia manufacturing b.v. - melatonin 3 mg - tablet - 3 mg - melatonin 3 mg - melatonin

Bélgica - inglés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vemedia manufacturing b.v. - melatonin 5 mg - tablet - 5 mg - melatonin 5 mg - melatonin

Israel - inglés - Ministry of Health

neurim pharmaceuticals (1991) ltd, israel - melatonin - tablets prolonged release - melatonin 2 mg - melatonin - melatonin - short-term treatment for primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

rad data australia pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; purified talc; magnesium stearate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

Estados Unidos - inglés - NLM (National Library of Medicine)

energique, inc. - melatonin (unii: jl5dk93rcl) (melatonin - unii:jl5dk93rcl) - may temporarily relieve symptoms associated with reactions to melatonin such as sleeplessness.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. may temporarily relieve symptoms associated with reactions to melatonin such as sleeplessness.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

nature's care manufacture pty limited - melatonin, quantity: 3 mg - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; sorbitol; magnesium stearate; colloidal anhydrous silica - melatonin may help people who experiencing occasional sleeplessness, those with jet lag, or anyone seeking to improve their quality of rest due to sleep disturbance

Australia - inglés - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; purified talc; magnesium stearate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

Namibia - inglés - Namibia Medicines Regulatory Council

trinity pharma (pty) ltd - melatonin - prolonged release tablet - eacch prolonged release tablet contains melatonin 2mg